EubioQuercetin®
See all EubioQuercetin® forms ranked
Scored by absorption, bioavailability & formulary tier
Quick Answer
What is the best form of EubioQuercetin®?
We compared 1 forms of EubioQuercetin® in our formulary. Browse the comparison table below to find the best form for your goals.
All Forms of EubioQuercetin®
| Form | Tier | Absorption Score | Dose Range | Unit |
|---|---|---|---|---|
| EubioQuercetin® | Customer Choice | 42/100Good | — | — |
Absorption by Form
What is EubioQuercetin®?
EubioQuercetin® is a supplement supplement available in 1 form.
Not all forms of EubioQuercetin® are equal. The form you choose determines how much EubioQuercetin® actually reaches your tissues, and the difference between the best and worst forms can be substantial. FormulaForge’s formulary ranks each form by bioavailability tier (S1–S4) and formulary tier (T1–T4), giving you a research-backed guide for choosing wisely.
Forms of EubioQuercetin® Compared
EubioQuercetin® (Customer Choice) has a bioavailability rating of high (S1 — best tier). Typical dose range: not yet documented in our database.
What the Research Shows
Quercetin aglycone bioavailability is exceptionally poor. Human RCT established 20x enhancement for lecithin phytosome (Quercefit). A 2025 meta-analysis of 31 human studies confirms this range, with advanced formulations reaching up to 62x enhancement.
Quercetin phytosome (Quercefit) demonstrated 20-fold higher plasma quercetin AUC compared to unformulated quercetin in a human crossover RCT. PMID: 30328058
2025 meta-analysis of 31 human quercetin studies confirms formulated versions achieve 20-62x bioavailability enhancement over standard aglycone. PMID: 40037045
Quercetin aglycone undergoes extensive phase II metabolism, resulting in less than 2% oral bioavailability, establishing the need for advanced delivery systems. PMID: 34194240
How to Choose the Right Form
Multiple forms of EubioQuercetin® are available. Start by comparing form ratings — Preferred Forms reflect the strongest bioavailability evidence, and S1-rated forms deliver the most active compound per dose unit.
The appropriate form depends on your individual goals and your healthcare provider’s recommendations. Consult a qualified professional before selecting a supplement form.
Dosing & Safety
For EubioQuercetin®, the typical dosing range is not yet documented in our database. Individual dose requirements vary based on health goals, body weight, and existing nutrient intake.
Side Effects: Specific side effect data for these forms is not yet documented in our database. In general, consult your healthcare provider regarding tolerability at higher doses.
These statements are based on structure/function research and have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting or changing a supplement regimen.
The Science
The following studies and findings inform FormulaForge classifications for EubioQuercetin®:
Quercetin phytosome (Quercefit) demonstrated 20-fold higher plasma quercetin AUC compared to unformulated quercetin in a human crossover RCT. PMID: 30328058
2025 meta-analysis of 31 human quercetin studies confirms formulated versions achieve 20-62x bioavailability enhancement over standard aglycone. PMID: 40037045
Quercetin aglycone undergoes extensive phase II metabolism, resulting in less than 2% oral bioavailability, establishing the need for advanced delivery systems. PMID: 34194240
Dosing Guidance
Dosing information not yet available for this ingredient.
Frequently Asked Questions
What is the best form of EubioQuercetin®?
How much EubioQuercetin® should I take?
What does EubioQuercetin® support?
Is EubioQuercetin® safe?
Ready to formulate with EubioQuercetin®?
Build your personalized formula with research-backed dosing.
Start My FormulaCompare & Learn More
References
- Quercetin phytosome (Quercefit) demonstrated 20-fold higher plasma quercetin AUC compared to unformulated quercetin in a human crossover RCT. PubMed
- 2025 meta-analysis of 31 human quercetin studies confirms formulated versions achieve 20-62x bioavailability enhancement over standard aglycone. PubMed
- Quercetin aglycone undergoes extensive phase II metabolism, resulting in less than 2% oral bioavailability, establishing the need for advanced delivery systems. PubMed
FormulaForge formulates and sells supplements containing the ingredients discussed on this page. Our formulary recommendations are based on peer-reviewed bioavailability research. All cited studies are independently verifiable.